National and International Invited Seminars/Lectures, Personalized medicine in breast cancer, University of Arizona Cancer Center, Tucson, AZ | 04/2017 |
Regional Invited Seminars/Lectures, Precision medicine in breast cancer, fiction or reality?, Cornell University, New York City, NY | 04/2017 |
Regional Invited Seminars/Lectures, Personalized medicine in breast cancer, University of Missouri, Columbia, MO | 03/2017 |
Regional Invited Seminars/Lectures, Precision medicine in breast cancer, fiction or reality?, USA Mitchel Cancer Institute, University of South Alabama, Mobile, AL, Mobile, AL | 03/2017 |
Poster Presentation, A Phase II study of ANG1005, A Novel Brain-Penetrant Taxane Derivative, for the Treatment of Recurrent Brain Metastases and Leptomeningeal Carcinomatosis from Breast Cancer, European Association of Neuro-Oncology, Mannheim, Germany | 10/2016 |
Oral Presentation, ANG1005, A Novel Peptide-paclitaxel Conjugate, Crosses the BBB and Shows Activity in Patients with Recurrent CNS Metastasis from Breast Cancer: Results from a Phase II Clinical Study, European Society for Medical Oncology, Copenhagen, Denmark | 10/2016 |
Poster Presentation, Impact of Health Disparities on Outcomes: Do Black Women with Inflammatory Breast Cancer Require Individualized Treatment Intensification?, American Society of Clinical Oncology (ASCO) Annual Meeting Abstracts, Augusta, GA | 09/2016 |
Poster Presentation, Immune Checkpoint Inhibitors (ICI): A Meta-analysis of Immune-related Adverse Events (irAE) from Cancer Clinical Trials, American Society of Clinical Oncology Annual Meeting Abstracts, Augusta, GA | 09/2016 |
Poster Presentation, A Meta-analysis of Immune-related Adverse Events (irAE) of Immune Checkpoint Inhibitors (ICI) from Cancer Clinical Trials, American Society of Clinical Oncology, Chicago, IL | 06/2016 |
Oral Poster Presentation, ANG1005, A Novel Brain-Penetrant Taxane Derivative, for the Treatment of Recurrent Brain Metastases and Leptomeningeal Carcinomatosis from Breast Cancer, American Society of Clinical Oncology (ASCO), Chicago, IL | 06/2016 |
Poster Presentation, A Phase II, Open-Label, Multi-Center Study of ANG1005, A Novel Brain-penetrant Taxane Derivative, in Breast Cancer Patients with Recurrent CNS Metastases, San Antonio Breast Cancer Symposium, San Antonio, TX | 12/2015 |
Poster Presentation, A Phase 2, Randomized Trial of the IDO Pathway Inhibitor Indoximod in Combination with Taxane Based Chemotherapy for Metastatic Breast Cancer: Preliminary Data, San Antonio Breast Cancer Symposium, San Antonio, TX | 12/2015 |
Poster Presentation, A Phase II Study of ANG1005, A Novel BBB/BCB Penetrant Taxane in Patients with Recurrent Brain Metastases and Leptomeningeal Carcinomatosis from Breast Cancer, Society of Neuro-Oncology Annual Meeting, San Antonio, TX | 11/2015 |
National and International Invited Seminars/Lectures, Personalized precision therapy in oncology, World Cancer Conference, Dubai, United Arab Emirates | 2015 |
Regional Invited Seminars/Lectures, San Antonio Breast Cancer Conference Update, Augusta, GA | 2015 |
National and International Invited Seminars/Lectures, Precision Medicine in Cancer, Current approach and future direction, Chinese Academy of Engineering, Changsha, China | 2015 |
National and International Invited Seminars/Lectures, Targeted therapy in breast cancer, Dubai, UAE | 2015 |
National and International Invited Seminars/Lectures, Personalized medicine in breast cancer, fiction or reality?, Changsha, China | 2015 |
National and International Invited Seminars/Lectures, The future of cancer treatment, World Forum of Academicians and University Presidents, Xuzhou, China | 2014 |
National and International Invited Seminars/Lectures, Clinical Trial Methodologies in Oncology, Annual Chinese Radiation Oncology Conference, Chengdu, China | 2014 |
National and International Invited Seminars/Lectures, Breast Cancer in 2014, the future is here., PCS Global Cancer Conference, Athens, Greece | 2014 |
State/Local Invited Seminars/Lectures, Overcoming resistance in HERZ-targeted therapy, GRU Cancer Center Research in Progress Seminars | 2014 |
National and International Invited Seminars/Lectures, Breast Cancer Therapy in 2014, Athens, Greece | 2014 |
National and International Invited Seminars/Lectures, Clinical Management of Advanced NSCLC, Satellite Symposium of the First Latin America Lung Cancer Conference, Guarujá City, Brazil | 2014 |
National and International Invited Seminars/Lectures, Breast Cancer Treatment, past, present and future, Sichuan Provincial Tumor Hospital, Chengdu, Sichuan, China | 2013 |
Regional Invited Seminars/Lectures, Highlights from 2012 San Antonio Breast Cancer Conference, Southdale Medical Center, Minneapolis, MN | 03/2012 |
National and International Invited Seminars/Lectures, San Antonio Breast Cancer Update, United Hospital Breast Cancer Tumor Board, Minneapolis, MN | 01/2012 |
National and International Invited Seminars/Lectures, Taxanes in breast cancer, past, present and future, Regional Cancer Conference, Shantou, Fujian, China | 2012 |
National and International Invited Seminars/Lectures, Breast Cancer in 2012, Western and Chinese Hospital, Taiyuan, China | 2012 |
National and International Invited Seminars/Lectures, Current progress in breast cancer, Peace Hospital, Shijiazhuang, China | 2012 |
National and International Invited Seminars/Lectures, Triple negative breast cancer, VPCI, Minneapolis, MN | 10/2011 |
National and International Invited Seminars/Lectures, Challenge of TNB, Update on Hematology and Oncology, Minneapolis, MN | 09/2011 |
National and International Invited Seminars/Lectures, SABCC review, VPCI, Minneapolis, MN | 01/2011 |
National and International Invited Seminars/Lectures, Bridging the gap between USA and Asia in Cancer Drug Research and Development, Global Breast Cancer Conference, Seoul, Korea | 2011 |
National and International Invited Seminars/Lectures, Comprehensive chemotherapy in advanced breast cancer, International Breast Cancer Conference, Tianjin, China | 2011 |
National and International Invited Seminars/Lectures, Cancer care between China and USA, Minnesota Chinese Cancer Forum, Minneapolis, MN | 10/2010 |
National and International Invited Seminars/Lectures, Breast Cancer, recent progress and future direction, Twin City Chinese Physician Association Annual meeting, Minneapolis-St. Paul, Minnesota | 09/2010 |
National and International Invited Seminars/Lectures, Predictive and prognostic factors in breast cancer, Breast Cancer Update, Minneapolis, MN | 08/2010 |
National and International Invited Seminars/Lectures, Challenging cases in metastatic breast cancer. Grand Rounds, John, B Amos Cancer Center, Columbus, GA | 2010 |
National and International Invited Seminars/Lectures, Prognostic and predictive markers in breast cancer. Update on Breast Cancer, Minneapolis, MN | 2010 |
National and International Invited Seminars/Lectures, ASCO update, 2010, Tianjin Tumor Institute and hospital, Tianjin, China | 2010 |
National and International Invited Seminars/Lectures, PARP inhibitors in breast cancer, Minneapolis, MN, VPCI breast journal club | 2010 |
National and International Invited Seminars/Lectures, Taxanes in breast cancer, VPCI breast journal club, Minneapolis, MN | 2010 |
National and International Invited Seminars/Lectures, Global collaboration in clinical trials, 2nd USCACA Annual Meeting, Chicago, USA, June | 2010 |
National and International Invited Seminars/Lectures, Targeted therapy in breast cancer, 4th Asia International Breast Cancer Summit, Xian, China | 2010 |
National and International Invited Seminars/Lectures, Breast Cancer: Recent development and future direction, 4th Asia International Breast Cancer Summit, Xian, China | 2010 |
National and International Invited Seminars/Lectures, 2008 SABCC update, Tumor Board. City of Hope Pasadena Clinic, Pasadena, CA | 2009 |
National and International Invited Seminars/Lectures, Optimizing hormonal therapy in early breast cancer, Tumor Board. Sutter Cancer Center, Sacramento. CA | 2009 |
Regional Invited Seminars/Lectures, Adjuvant hormonal therapy for early breast cancer, Grand Round. Marian Medical Center, Santa Maria, CA | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Adjuvant hormonal therapy for early breast cancer, Marian Medical Center, Santa Maria, CA | 2009 |
National and International Invited Seminars/Lectures, Fellows Teaching Rounds: Update in hormonal therapy of early breast cancer, Ellis Fischel Cancer Center, University of Missouri in Columbia, Columbia, MO | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds: Adjuvant therapy in early breast cancer, Madrona Medical Center, Bellingham, WA | 2009 |
National and International Invited Seminars/Lectures, Tumor Board: Current hormonal therapy in early breast cancer, St. Joseph Regional Cancer Center, Lewiston, ID | 2009 |
National and International Invited Seminars/Lectures, Adjuvant Therapy for Early Breast Cancer. Tumor Board, Virginia G. Piper Cancer Center, Phoenix, AZ | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Optimizing Hormonal Therapy in Early Breast Cancer, Oklahoma University Cancer Center, Oklahoma City, OK | 2009 |
National and International Invited Seminars/Lectures, American Society of Clinical Oncology Annual meeting Review in Breast Cancer, Central Alabama Hematology and Oncology Forum, Birmingham, AL | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds: Adjuvant therapy in early breast cancer, Madrona Medical Center, Bellingham, WA | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Adjuvant hormonal therapy in early breast cancer, Good Samaritan Hospital, Los Angeles, CA | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Update in hormonal therapy of early breast cancer, Lakewood Rocky Mountain Cancer Center, Denver, CO | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Adjuvant hormonal therapy in early breast cancer, Comprehensive Cancer Center of Nevada, Las Vegas, NV | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Chemotherapy in metastatic breast cancer, an update, Fairview Redwing Medical Center, Redwing, MN | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Novel taxanes in metastatic breast cancer, Trinity Cancer Center, Birmingham, AL | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Update in chemotherapy of metastatic breast cancer, Southern Cancer Center | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Chemotherapy in metastatic breast cancer, an update, Hutchinson Medical Center, Hutchinson, MN | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Novel taxanes in metastatic breast cancer, Northfield Hospital, Northfield, MN | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Update in chemotherapy of metastatic breast cancer, New Ulm Medical Center, New Ulm, MN | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Update in chemotherapy of metastatic breast cancer, Prairie Lakes Cancer Center, Watertown, SD | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Chemotherapy in metastatic breast cancer, an update, Trinity Cancer Center, Minot, ND | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Update in chemotherapy of metastatic breast cancer, Mid-Dakota Cancer Center, Bismarck, ND | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Chemotherapy in early breast cancer, an update, South Austin Cancer Center, Austin, TX | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Taxanes in early breast cancer, John Peter Smith Cancer Center, Ft. Worth, TX | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Update in chemotherapy of early breast cancer., The center for cancer and blood disorders, Ft. Worth, TX | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Update in chemotherapy of early breast cancer, Stony Brook University Hospital, Stony Brook, NY | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Taxanes in early breast cancer, Alamance Regional Cancer Center, Burlington, NC | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Update in early breast cancer chemotherapy, John Peter Smith Cancer Center, University of New Mexico Cancer Treatment South, Las Cruses, NM | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Taxanes in early breast cancer., John Peter Smith Cancer Center., Ft. Worth, TX | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Current chemotherapy in early breast cancer, Roswell Regional Hospital, Roswell, NM | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Taxanes in early breast cancer, Medical College of Wisconsin, Milwaukee, WI | 2009 |
National and International Invited Seminars/Lectures, Tumor Board. Taxanes in early breast cancer, Racine, WI, Wheaton Franciscan Health Care | 2009 |
National and International Invited Seminars/Lectures, Grand Rounds. Current chemotherapy in early breast cancer, Columbia St. Marys Cancer Center, Milwaukee, WI | 2009 |
National and International Invited Seminars/Lectures, Update in chemotherapy of early breast cancer, Tianjin Medical University Cancer Institute and hospital, Tianjin, China | 2009 |
National and International Invited Seminars/Lectures, Current approach in hormonal therapy in early breast cancer, Xiamen, Fujian, China | 2009 |
National and International Invited Seminars/Lectures, Angiogenesis inhibitors in breast cancer, Shenzhen, China | 2009 |
National and International Invited Seminars/Lectures, Highlights in breast cancer from ASCO 2009, Chinese Southwest Oncology Group Annual Meeting, Dongguan, Guangdong, China | 2009 |
National and International Invited Seminars/Lectures, Challenges in chemotherapy of early breast cancer, Regional Breast Cancer Conference, Guilin, Guangxi, China | 2009 |
National and International Invited Seminars/Lectures, Unique opportunity in collaboration between USA and China on cancer clinical trials, US Chinese American Anti-cancer Association Launch Meeting, Denver, CO, USA | 2009 |
National and International Invited Seminars/Lectures, Global collaboration on clinical trials in breast cancer, 3rd Asia International Breast Cancer Summit, Chengdu, China | 2009 |
National and International Invited Seminars/Lectures, Predictive markers of taxane response in breast cancer, 3rd Asia International Breast Cancer Summit, Chengdu, China | 2009 |
National and International Invited Seminars/Lectures, Novel taxanes e in breast cancer, 3rd Asia International Breast Cancer Summit, Chengdu, China | 2009 |
National and International Invited Seminars/Lectures, Overcoming Trastuzumab resistance in breast cancer, 3rd Asia International Breast Cancer Summit, Chengdu, China | 2009 |
National and International Invited Seminars/Lectures, Current approaches in hormonal management of early breast cancer, 7th Global Breast Cancer Conference, Seoul, Korea | 2009 |
National and International Invited Seminars/Lectures, Update in hormonal management of early breast cancer, Tumor Board, ION Group, Albuquerque, NM | 2008 |
National and International Invited Seminars/Lectures, Grand Rounds, Current approaches in hormonal therapy in early breast cancer., Cancer Care Center of the Rockies, Ft. Collins, CO | 2008 |
National and International Invited Seminars/Lectures, Optimal hormonal therapy in early breast cancer, University of Colorado Denver Health, Denver, CO | 2008 |
National and International Invited Seminars/Lectures, Update in hormonal management of early breast cancer., Tumor Board. Sutter Cancer Center, Sacramento, CA | 2008 |
National and International Invited Seminars/Lectures, Current approaches in hormonal therapy in early breast cancer., Grand Round. Memorial Hospital, Colorado Springs, CO | 2008 |
National and International Invited Seminars/Lectures, Current approaches in hormonal therapy in early breast cancer, Grand Rounds. Nebraska Cancer Center, Lincoln, NB | 2008 |
National and International Invited Seminars/Lectures, Tumor board: Christian Northeast Hospital. Hormonal management of early breast cancer, SABCC 2007 update, St. Louis, MO | 2008 |
National and International Invited Seminars/Lectures, Grand Rounds: Current approaches in hormonal therapy in early breast cancer, St. Marks Hospital, Salt Lake City, UT | 2008 |
National and International Invited Seminars/Lectures, Optimizing hormonal therapy in early breast cancer, University of New Mexico, Albuquerque, NM | 2008 |
National and International Invited Seminars/Lectures, Challenging cases in breast cancer hormonal therapy, IX International Aromatase Conference, Shanghai, China | 2008 |
National and International Invited Seminars/Lectures, Recent advances in the adjuvant treatment of early breast cancer, 8th Chinese Breast Cancer Conference, Chongqing, China | 2008 |
National and International Invited Seminars/Lectures, Biomarkers of resistance to tubulin-targeting agents, Annual Taiwanese Oncology Meeting, Taipei | 2008 |
National and International Invited Seminars/Lectures, Current clinical trials in North America, The Global Surgical Meeting, Hangzhou, China | 2008 |
National and International Invited Seminars/Lectures, Advances in the treatment of refractory metastatic breast cancer., 10th Annual Lynn Sage Breast Cancer Symposium, Chicago | 2008 |
National and International Invited Seminars/Lectures, Current Approached in the Hormonal Management of Early Breast Cancer, Grand Round, University of Colorado Cancer Center, Denver, CO | 2007 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Management of Early Breast Cancer, Grand Round, Dartmouth University Norris Cotton Cancer Center, Lebanon, NH | 2007 |
National and International Invited Seminars/Lectures, San Antonio Breast Cancer Conference Update, Pacific Oncology Annual Oncology Conference, Portland, OR | 2007 |
National and International Invited Seminars/Lectures, San Antonio Breast Cancer Conference Update, Fellows Tumor Conference, University of Colorado, Denver, CO | 2007 |
National and International Invited Seminars/Lectures, EGFR-targeted Therapy in Early Breast Cancer, Grand Round, Providence Hospital, El Paso, TX | 2007 |
National and International Invited Seminars/Lectures, Current Approached in the Hormonal Management of Early Breast Cancer, Grand round, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA | 2007 |
National and International Invited Seminars/Lectures, Optimal hormonal therapy for early breast cancer, First Asia Breast Cancer Summit, Beijing, China | 2007 |
National and International Invited Seminars/Lectures, Current Approaches in the chemotherapy of early breast cancer, Sino-American Breast Conference, Xian, China | 2007 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Management of Early Breast Cancer, Grand Round. University of Nebraska, Omaha, NB | 2006 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Management of Early Breast Cancer, Tumor Board, UCLA, Los Angeles, CA | 2006 |
National and International Invited Seminars/Lectures, EGFR-Targeted Therapy in MBC, Tumor Board, University of Colorado, Denver, CO | 2006 |
National and International Invited Seminars/Lectures, Novel Taxanes in Breast Cancer, Tumor Board, University of Minnesota, MN | 2006 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, Oncology Grand Round, Rush University Medical Center, Chicago, IL | 2006 |
National and International Invited Seminars/Lectures, Chemotherapy in Lung Cancer, Oncology Grand Round, Mayo Clinic, Scottsdale, AZ | 2006 |
National and International Invited Seminars/Lectures, Current Hormonal Management of Early Breast Cancer, Texas Oncology Nursing Society, Austin, TX | 2006 |
National and International Invited Seminars/Lectures, Taxanes in Breast Cancer, current approach and future direction, Mexico Clinical Oncology Society Annual Meeting | 2006 |
National and International Invited Seminars/Lectures, Locally Advanced NSCLC, the US Experience, 3rd Pan Pacific Lung Cancer Conference, Shanghai, China | 2006 |
National and International Invited Seminars/Lectures, Current Hormonal Therapy in Early Breast Cancer, Annual Chinese Society of Clinical Oncology, Beijing, China | 2006 |
National and International Invited Seminars/Lectures, Lung Cancer Screening, controversy and ongoing research., Mayo Clinic Medicine Forum. Scottsdale, AZ | 2006 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Anti-apoptotic Tumor Marker, Grand Round, University of Texas Southwestern Medical Center at Dallas Simmons Cancer Center, Dallas, TX | 2005 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Anti-apoptotic Tumor Marker, Grand Round, Moffitt Cancer Center, Tampa, FL | 2005 |
National and International Invited Seminars/Lectures, Taxanes in Early Breast Cancer, Urumqi, Chengdu, Jinan and Nanjing, China | 2005 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Anti-apoptotic Tumor Marker: From Laboratory to Clinical Practice, Grand Round, University of Florida, Gainesville, FL | 2005 |
National and International Invited Seminars/Lectures, Update in Chemotherapy in Lung Cancer, Grand Round, Nevada Cancer Institute, Las Vegas, NV | 2005 |
National and International Invited Seminars/Lectures, Current Hormonal Management of Early Breast Cancer, Grand Round, Long Island Cancer Center, State University of New York at Stony Brook, Stony Brook, NY | 2005 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Management of Early Breast Cancer, Tumor Board, University of Texas Medical Branch, Galveston, TX | 2005 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Anti-apoptotic Tumor Marker: From Laboratory to Clinical Practice, Grand Round, University of West Virginia, Charlottesville, VA | 2005 |
National and International Invited Seminars/Lectures, Update in Chemotherapy for NSCLC, Best Practices in Oncology, Richmond, VA | 2005 |
National and International Invited Seminars/Lectures, Current Strategy in the Hormonal Treatment of Early Breast Cancer, Taiwan Breast Cancer Society Conference, Kaohsiung, Taiwan | 2005 |
National and International Invited Seminars/Lectures, New Direction for Breast Cancer Treatment: Increasing Efficacy and Decreasing Toxicity, KL, Malaysia | 2005 |
National and International Invited Seminars/Lectures, Current Hormonal Management of Early Breast Cancer, Grand Round, Northridge Hospital, Northridge, CA | 2005 |
National and International Invited Seminars/Lectures, Optimizing Hormonal Therapy in Early Breast Cancer, Annual Meeting of the Israeli Oncology Society, Eilat, Israel | 2005 |
National and International Invited Seminars/Lectures, Targeted Therapy in Breast Cancer, XXII Joint Annual Meeting of Panamanian Oncology Society and NCI Mexico, Panama City, Panama | 2005 |
National and International Invited Seminars/Lectures, Optimizing Chemotherapy in Early Breast Cancer, North China Breast Cancer Forum, Beijing, China | 2005 |
National and International Invited Seminars/Lectures, Current Principles of Chemotherapy in Early and Advanced Breast Cancers, First African Oncology Conference, Nairobi, Kenya | 2005 |
National and International Invited Seminars/Lectures, Changing Paradigm of Adjuvant Hormonal Therapy in Early Breast Cancer, First African Oncology Conference, Nairobi, Kenya | 2005 |
National and International Invited Seminars/Lectures, Expanding Role of Bisphosphonates in Solid Tumor, 7th Chinese National Metastatic Cancer Conference, Chengdu, Sichuan, China | 2005 |
National and International Invited Seminars/Lectures, Current Strategy in the Hormonal Treatment of Early Breast Cancer, Taiwan Breast Cancer Society Conference, Taipei, Taiwan | 2005 |
National and International Invited Seminars/Lectures, Current Strategy in the Hormonal Treatment of Early Breast Cancer, Hong Kong Society of Clinical Oncology and Hong Kong College of Radiologists Conference, Hong Kong, China | 2005 |
National and International Invited Seminars/Lectures, Optimizing Hormonal Therapy in Early Breast Cancer, Malaysia and Singapore Oncology Society Joint Scientific Meeting, Johor Bahru, Malaysia | 2005 |
National and International Invited Seminars/Lectures, Hormonal Management of Early Breast Cancer: Current Data and Future Directions, Costa Rica Oncology Society Conference, San Jose, Costa Rica | 2005 |
National and International Invited Seminars/Lectures, Aromatase Inhibitors in Breast Cancer, 3rd AFME Symposium, Istanbul, Turkey | 2005 |
National and International Invited Seminars/Lectures, Novel Agents in Breast Cancer, 1st LACORE Summit, Iguacu, Brazil | 2005 |
National and International Invited Seminars/Lectures, Aromatase Inhibitors in Metastatic Breast Cancer, 1st LACORE Summit, Iguacu, Brazil | 2005 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Therapy in Early Breast Cancer, The BIG Caribbean Meeting, Tikal, Guatemala | 2005 |
National and International Invited Seminars/Lectures, Current Strategy in the Hormonal Management of Early Breast Cancer, Central Latin American Oncology Forum, Santo Domingo, Dominican Republic | 2005 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Therapy in Early Breast Cancer, XXII Joint Annual Meeting of Panamanian Oncology Society and NCI Mexico, Panama City, Panama | 2005 |
National and International Invited Seminars/Lectures, Highlights from 2003 SABCC, Grand Rounds, Glendale Memorial Hospital and Health Center, CA | 2004 |
National and International Invited Seminars/Lectures, Grand Rounds: Changing Paradigm of Adjuvant Hormonal Therapy in Early Breast Cancer, UCLA Harbor Medical Center, Los Angeles, CA | 2004 |
National and International Invited Seminars/Lectures, Anemia in Cancer Patients, Oncology Nursing Society Florida Chapter Annual Meeting, Tampa, FL | 2004 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, National Iressa Launch Meeting, Antigua Guatemala | 2004 |
National and International Invited Seminars/Lectures, Update on Adjuvant Hormonal Therapy in Early Breast Cancer, Post-ASCO Review, Grand Round, Pocono Medical Center, Stroudsburg, PA | 2004 |
National and International Invited Seminars/Lectures, Future Direction of Epidermal Growth Factor Inhibitors in Solid Tumor, Monterrey, Mexico | 2004 |
National and International Invited Seminars/Lectures, Future Direction of Epidermal Growth Factor Inhibitors in Solid Tumor, National Iressa Launch Meeting, Mexico City, Mexico | 2004 |
National and International Invited Seminars/Lectures, Update on Breast Cancer, Grand Round, NCH Health Care System, Naples, FL | 2004 |
National and International Invited Seminars/Lectures, Update on the Adjuvant Therapy of Early Breast Cancer, Shanghai Cancer Institute, Shanghai, China | 2004 |
National and International Invited Seminars/Lectures, Systemic Therapy in Advanced NSCLC, Guarujá City, Brazil | 2004 |
National and International Invited Seminars/Lectures, Use of Aromatase Inhibitors in Advanced Breast Cancer, Novartis First Asia Pacific Oncology Summit, Hainan, China | 2004 |
National and International Invited Seminars/Lectures, Current Strategy in the Adjuvant Treatment of Breast Cancer, Ormond Beach, FL | 2004 |
National and International Invited Seminars/Lectures, Highlights from 2003 SABCC, Tumor Board, Olive View Medical Center, CA | 2004 |
National and International Invited Seminars/Lectures, Highlights from 2003 SABCC, Grand Rounds, Cancer Center of Santa Barbara, Santa Barbara, CA | 2004 |
National and International Invited Seminars/Lectures, Highlights from 2003 SABCC, Encino-Tarzana Regional Medical Center Grand Rounds, Burbank, CA | 2004 |
National and International Invited Seminars/Lectures, Changing Paradigm of Hormonal Therapy in Early Breast Cancer, 8th Korean Breast Cancer Society Annual Conference, Seoul, Korea | 2004 |
National and International Invited Seminars/Lectures, Extended Adjuvant Therapy in Early Breast Cancer, Mexico Annual Mastology Conference, Acapulco, Mexico | 2004 |
National and International Invited Seminars/Lectures, Current Management of Advanced NSCLC, Guatemala National Oncology Conference, Guatemala City, Guatemala | 2004 |
National and International Invited Seminars/Lectures, Angiogenesis and Apoptosis in Breast Cancer, Second Inter-American Breast Cancer Conference, Cancun, Mexico | 2004 |
National and International Invited Seminars/Lectures, Polychemotherapy in the Adjuvant Treatment of Early Breast Cancer, 9th Annual Conference of the Association of Clinical Oncology of Taiwan, Taipei, Taiwan | 2004 |
National and International Invited Seminars/Lectures, Changing Paradigm in the Hormonal Management of Early Breast Cancer, 7th Annual Chinese Society of Clinical Oncology Conference, Kunming, China | 2004 |
National and International Invited Seminars/Lectures, Aromatase Inhibitors in Early Breast Cancer, Asia Breast Cancer Conference, Taipei, Taiwan | 2004 |
National and International Invited Seminars/Lectures, Differential anti-apoptotic functions of BAG-1 isoforms in breast cancer cells in the presence of estrogen and anti-estrogen., 27th San Antonio Breast Cancer Conference | 2004 |
National and International Invited Seminars/Lectures, FLJ2040 gene: A novel up-regulator of BAG-1 expression., American Association for Cancer Research Annual Meeting | 2004 |
National and International Invited Seminars/Lectures, Differential anti-apoptotic functions of BAG-1 isoforms in breast cancer cells in presence of estrogen and anti-estrogen., 95th American Association for Cancer Research Annual Meeting | 2004 |
National and International Invited Seminars/Lectures, Update on the Management of Advanced NSCLC, Arizona Clinical Oncology Society, Phoenix, AZ | 2003 |
National and International Invited Seminars/Lectures, Current Issues and Future Direction in Clinical Oncology, University of Arizona, Tucson, AZ | 2003 |
National and International Invited Seminars/Lectures, BAG-1, A Novel Anti-apoptotic Tumor Marker in NSCLC, University of West Virginia Annual Lung Cancer Research Meeting, Morgantown, WV | 2003 |
National and International Invited Seminars/Lectures, Small Cell Lung Cancer Evolving Approaches, University of Florida Thoracic Oncology Update 2003 Symposium, Jacksonville, Florida | 2003 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, West China University of Medical Sciences, Chengdu, China | 2003 |
National and International Invited Seminars/Lectures, Update on the Treatment of SCLC, Joint Cancer Conference of Florida Universities, Orlando, Florida | 2003 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, Latin America Oncology Conference, Curacao | 2003 |
National and International Invited Seminars/Lectures, Platinum vs. Non-Platinum Doublets in Advanced NSCLC According to BAG-1 Expression, ECOG Lung Cancer Committee, New Orleans | 2003 |
National and International Invited Seminars/Lectures, Open Label Phase II Trial of Targretin in Stage III NSCLC after Chemoradiation, ECOG Lung Cancer Committee, New Orleans | 2003 |
National and International Invited Seminars/Lectures, BAG-1, an Anti-apoptotic Tumor Marker, Department of Immunology and Microbiology, University of Miami, Miami, Florida | 2003 |
National and International Invited Seminars/Lectures, Targeted Therapy in Cancer, Clinician Scientist Course, University of Miami, Miami, Florida | 2003 |
National and International Invited Seminars/Lectures, New Insight into the Anemia and Lung Cancer, Grand Round, VA Hospital, West Palm Beach, Florida | 2003 |
National and International Invited Seminars/Lectures, American Society of Clinical Oncology Annual Meeting Review in Breast Cancer, Georgia Cancer Foundation, Macon, Georgia | 2003 |
National and International Invited Seminars/Lectures, Integration of Epirubicin in the Management of Breast Cancer, NOCR Regional Advisory Board, Las Vegas, Arizona | 2003 |
National and International Invited Seminars/Lectures, Exploring Diagnosis and Treatment of Advanced NSCLC, Stuart, Florida | 2003 |
National and International Invited Seminars/Lectures, American Society of Clinical Oncology Annual Meeting Review in Breast Cancer, South Carolina Oncology Associate Annual Meeting, Columbia, South Carolina | 2003 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, National Oncology Conference, Mexico City, Mexico | 2003 |
National and International Invited Seminars/Lectures, New Insight into the Anemia and Breast Cancer, Grand Rounds, Baptist Hospital, Miami, FL | 2003 |
National and International Invited Seminars/Lectures, Update on the Treatment of SCLC, Tumor Board, St. Vincent Hospital, University of Florida, Jacksonville, FL | 2003 |
National and International Invited Seminars/Lectures, Anemia and Breast Cancer, New Data and Future Direction, Grand Round, Cedar Hospital, Miami, FL | 2003 |
National and International Invited Seminars/Lectures, Chemotherapy in Advanced Lung and Breast Cancer, Choosing the Right Drugs, Chongqing, Hong Kong (Prince of Whales Hospital, Queen Marys Hospital and Chinese University of Hong Kong Hospital), Beijing, Xian and Jinan, China | 2003 |
National and International Invited Seminars/Lectures, Therapeutic Options in SCLC, Seattle, WA | 2003 |
National and International Invited Seminars/Lectures, New Chemotherapy Options in Metastatic Breast Cancer, Asian Clinical Oncology Society Annual Meeting, Seoul, Korea | 2003 |
National and International Invited Seminars/Lectures, BAG-1 as a Novel Prognostic Tumor Marker, Latin America Oncology Conference, Curacao | 2003 |
National and International Invited Seminars/Lectures, Current Management of NSCLC, Latin America Oncology Conference, Curacao | 2003 |
National and International Invited Seminars/Lectures, Current Management of NSCLC, National Oncology Conference, Mexico City, Mexico | 2003 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, Latin America Oncology Forum, Mexico City, Mexico | 2003 |
National and International Invited Seminars/Lectures, Current Management of Advanced NSCLC, Argentina National Oncology Conference, Cordova, Argentina | 2003 |
National and International Invited Seminars/Lectures, Integration of EGFRI in Oncology Practice, Current Data and Future Direction, Argentina National Oncology Conference, Cordova, Argentina | 2003 |
National and International Invited Seminars/Lectures, Targeted Therapy in NSCLC, First West China Oncology Cooperative Group Annual Meeting, Chengdu, Sichuan, China | 2003 |
National and International Invited Seminars/Lectures, Optimizing Adjuvant Chemotherapy in Early Breast Cancer, Asian Clinical Oncology Society Annual Meeting, Seoul, Korea | 2003 |
National and International Invited Seminars/Lectures, Phase I clinical trial with Topotecan, Adriamycin and Vincristine (TAV) in patients with advanced small (SCLC) and non-small cell lung cancer (NSCLC)., 10th World Conference on Lung Cancer | 2003 |
National and International Invited Seminars/Lectures, Immunotherapy with gene-modified allogenic cells successfully induced CD8 T cell and clinical responses in patients with advanced non-small cell lung cancer (NSCLC)., 10th World Conference on Lung Cancer | 2003 |
National and International Invited Seminars/Lectures, Weekly carboplatin and docetaxel as neoadjuvant therapy in locally advanced and inflammatory breast cancers that do not express HER-2., American Society of Clinical Oncology Annual Meeting | 2003 |
National and International Invited Seminars/Lectures, Cardiotoxicity of Neoadjuvant Trastuzumab, Docetaxel and Cisplatin as related to BMI., American Society of Clinical Oncology Annual Meeting | 2003 |
National and International Invited Seminars/Lectures, Differential Diagnosis of Patient with Generalized Lymphadenopathy, Morbidity and Mortality Rounds, Jackson Memorial Hospital, University of Miami, Miami, Florida | 2002 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Prognostic Tumor Marker, Department of Medicine, University of Miami, Miami, Florida | 2002 |
National and International Invited Seminars/Lectures, Morbidity and Mortality Rounds, Department of Medicine, University of Miami, Miami, Florida | 2002 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Prognostic Tumor Marker, Department of Microbiology and Immunology, University of Miami, Florida | 2002 |
National and International Invited Seminars/Lectures, Update on Lung Cancer Biology and Treatment, Grand Round, Department of Medicine, University of Miami, Miami, Florida | 2002 |
National and International Invited Seminars/Lectures, Current Management of NCSLC, Department of Medicine, University of Miami, Miami, Florida | 2002 |
National and International Invited Seminars/Lectures, Predictive and Prognostic Markers in Breast Cancer, Clinical and Therapeutic Implications, Advances of Diagnosis and Treatment in Oncology, International Scientific Symposium, La Plata, Argentina | 2002 |
National and International Invited Seminars/Lectures, Novel Therapies in NSCLC, Gene Therapy, Advances of Diagnosis and Treatment in Oncology, International Scientific Symposium, La Plata, Argentina | 2002 |
National and International Invited Seminars/Lectures, Adjuvant Hormonal Therapy in Breast Cancer, First Inter-American Breast Cancer Conference, Cancun, Mexico | 2002 |
National and International Invited Seminars/Lectures, Prognostic Significance of BAG-1 Expression in Breast Cancer, First Inter-American Breast Cancer Conference, Cancun, Mexico | 2002 |
National and International Invited Seminars/Lectures, Prognostic significance of apoptosis proteins in local-regional recurrence of breast cancer, American Society of Clinical Oncology Annual Meeting | 2002 |
National and International Invited Seminars/Lectures, Sensitization to apoptosis by antisense BAG-1 is mediated by multiple apoptotic pathways., Zubrod Memorial Lecture and Annual Poster Presentation, University of Miami Sylvester Comprehensive Cancer Center | 2002 |
National and International Invited Seminars/Lectures, Expression of Mcl-1 predicts absence of local-regional recurrence of breast carcinoma., San Antonio Breast Cancer Symposium | 2002 |
National and International Invited Seminars/Lectures, Expression of BAG-1 correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptor in invasive breast carcinoma., 93rd American Association for Cancer Research Annual Meeting | 2002 |
National and International Invited Seminars/Lectures, Final results of the phase III randomized trial comparing docetaxel (T), doxorubicin (A) and cyclophosphamide (C) to FAC as first line chemotherapy (CT) for patients (pts) with metastatic breast cancer (MBC)., American Society of Clinical Oncology Annual Meeting | 2002 |
National and International Invited Seminars/Lectures, Final results of the phase III randomized trial comparing docetaxel (T), doxorubicin (A) and cyclophosphamide (C) to FAC as first line chemotherapy (CT) for patients (pts) with metastatic breast cancer (MBC)., American Society of Clinical Oncology Annual Meeting | 2002 |
National and International Invited Seminars/Lectures, BAG-1 isoforms have different anti-apoptotic functions., American Society of Clinical Oncology Annual Meeting | 2002 |
National and International Invited Seminars/Lectures, Expression of BAG-1 correlates with p53, Bcl-2, differentiation, estrogen receptor and progesterone receptor in invasive breast cancer., Expression of BAG-1 correlates with p53 | 2002 |
National and International Invited Seminars/Lectures, BAG-1, a Novel Tumor Marker, Sylvester Comprehensive Cancer Center Miami, Florida | 09/2001 |
National and International Invited Seminars/Lectures, New Hormonal Therapy for Breast Cancer, Xian, China | 09/2001 |
National and International Invited Seminars/Lectures, Open Label, Phase II Multicentre Study of Taxotere, Adriamycin, Cyclophosphamide (TAC) Combination Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer, 7th Central European Lung Cancer Conference, Prague, Czech Republic | 06/2001 |
National and International Invited Seminars/Lectures, Hope and Challenge of Breast Cancer Care in the New Millennium, 2nd Breast Cancer Survivor Retreat, Gros Morne, Newfoundland | 05/2001 |
National and International Invited Seminars/Lectures, Emerging Role of Letrozole in Metastatic Breast Cancer, Atlantic Canada Oncology Group 5th Annual Winter Symposium, Corner Brook, Newfoundland | 02/2001 |
National and International Invited Seminars/Lectures, Adding Xeloda (X, Capecitabine) to Docetaxel (D) significantly improves survival and does not compromise QoL in patients with MBC., San Antonio Breast Cancer Symposium | 2001 |
National and International Invited Seminars/Lectures, A phase III randomized trial comparing Docetaxel (T), Doxorubicin (A) and Cyclophosphamide (C) (TAC) to FAC as first line chemotherapy (CT) for patients (pts) with metastatic breast cancer (MBC)., American Society of Clinical Oncology Annual Meeting | 2001 |
National and International Invited Seminars/Lectures, BAG-1, A Novel Antiapoptotic Prognostic Tumor Marker, Moffitt Cancer Center, Tampa, Florida | 10/2000 |
National and International Invited Seminars/Lectures, A Novel Prognostic Factor in Non-Small Cell Lung Cancer, 5th World Congress on Advances in Oncology and 3rd International Symposium on Molecular Medicine, Greece | 10/2000 |
National and International Invited Seminars/Lectures, BAG-1, A Novel Anti Apoptotic Prognostic Tumor Marker, Ottawa Cancer Center, Ottawa | 09/2000 |
National and International Invited Seminars/Lectures, Prognostic Significance of BAG-1 Expression in Non-Small Cell Lung Cancer, 9th World Conference on Lung Cancer, Tokyo, Japan | 09/2000 |
National and International Invited Seminars/Lectures, Challenges of Clinical Trials in a Small Academic Center, Thunder Bay, Thunder Bay | 05/2000 |
National and International Invited Seminars/Lectures, Small Cell Lung Cancer: The Promise of the New Drugs, 4th Atlantic Canada Oncology Group Annual Symposium, Corner Brook, Newfoundland | 02/2000 |
National and International Invited Seminars/Lectures, Multidrug resistance in human cervical cells is associated with enhanced expression of anti-apoptotic proteins BAG-1 and BCL-XL and reduced Caspase-3 activity., American Association for Cancer Research 91st Annual Meeting | 2000 |
National and International Invited Seminars/Lectures, Prognostic significance of BAG-1 expression in non-small-cell lung cancer (NSCLC)., American Society of Clinical Oncology Annual Meeting | 2000 |
National and International Invited Seminars/Lectures, Prognostic value of BAG-1 in NSCLC, Canadian Association of Medical Oncologists Annual Meeting | 2000 |
National and International Invited Seminars/Lectures, BAG-1, A Novel Prognostic Marker for Breast Cancer, Breast Cancer Research, Reasons for Hope: NCIC National Scientific Conference, Toronto | 06/1999 |
National and International Invited Seminars/Lectures, Eprex in Anemic Cancer Patients, Atlantic Experience, Cancer Care Nova Scotia, Halifax | 06/1999 |
National and International Invited Seminars/Lectures, Herceptin, the Great Canadian Debate Panelist, NCIC Satellite Symposium | 04/1999 |
Poster Presentation, BAG-1 is Generated as Four Isoforms by Alternative Translation Initiation and is Over-expressed in Cervical Cancer Cell, Proceedings of 17th International Papillomavirus Conference, Charleston, South Carolina | 01/1999 |
National and International Invited Seminars/Lectures, Small Cell Lung Cancer, the Promise of New Drugs, Chinese Lung Cancer Symposium, Chengdu, China | 1999 |
National and International Invited Seminars/Lectures, BAG-1 is generated as four isoforms by alternative translation initiation and is over-expressed in cervical cancer cell., 17th International Papillomavirus Conference | 1999 |
National and International Invited Seminars/Lectures, Multidrug resistance in human cervical cells is associated with enhanced expression of anti-apoptotic proteins BAG-1 and BCL-XL and reduced caspase-3 activity, AACR 91st Annual Meeting | 1999 |
National and International Invited Seminars/Lectures, BAG-1, a novel prognostic marker for breast cancer., Breast Cancer Research: Reasons for Hope, National Scientific Conference | 1999 |
National and International Invited Seminars/Lectures, Epoetin alfa reduces transfusion requirements, increase hemoglobin (Hb) and improves quality of life (QofL) in cancer patients with anemia who are not receiving concomitant chemotherapy., American Society of Clinical Oncology Annual Meeting | 1999 |
National and International Invited Seminars/Lectures, Interaction of BAG-1p50 with the vitamin D receptor suppresses vitamin D-mediated inhibition of proliferation., American Association for Cancer Research Annual Meeting | 1999 |
National and International Invited Seminars/Lectures, Association of BAG-1 with poor survival in breast cancer patients., American Society of Clinical Oncology Annual Meeting | 1999 |
National and International Invited Seminars/Lectures, Expression of apoptotic-associated proteins in multi-drug resistant human cervical cells., Third Atlantic Canada Oncology Group Winter Symposium | 1999 |
State/Local Invited Seminars/Lectures, Resistance to apoptosis induced by DNA damage during cervical Oncogenesis: Correlation with the expression of anti-apoptotic gene BAG-1., Third Atlantic Canada Oncology Group Winter Symposium | 1999 |
State/Local Invited Seminars/Lectures, Expression of BAG-1, p53 and Bcl-2 in lung carcinoma., Third Atlantic Canada Oncology Group Winter Symposium | 1999 |
National and International Invited Seminars/Lectures, Prognostic Value of BAG-1 in Breast Cancer, 2nd Atlantic Canada Oncology Group Annual Symposium, Corner Brook, NF, Canada | 1998 |
National and International Invited Seminars/Lectures, Update in Breast Cancer Chemotherapy, ASCO Review, St. Johns, NF, Canada | 1998 |
National and International Invited Seminars/Lectures, Anemia in Cancer Patients, Charlottetown, Prince Edward Island, Canada | 1998 |
National and International Invited Seminars/Lectures, Modern Chemotherapy for Advanced NSCLC, Second Chinese Society of Clinical Oncology Satellite Symposium, Nanjing, China | 1998 |
National and International Invited Seminars/Lectures, New Hormonal Therapies for Breast Cancer, Chengdu, Beijing, Guangzhou, Shenyang, China | 1998 |
National and International Invited Seminars/Lectures, Induction of caspase-3-like dependent and independent bimodal apoptosis in human malignant cervical cells by the alkaloid Sanguinarine., International Business Communications Fifth Annual Conference on Apoptosis | 1998 |
National and International Invited Seminars/Lectures, A Novel Prognostic Factor in Invasive Breast Cancer, Second Chinese Society of Clinical Oncology, Nanjing, China | 1998 |
National and International Invited Seminars/Lectures, A novel vitamin D receptor binding protein., American Association for Cancer Research Annual Meeting | 1998 |
National and International Invited Seminars/Lectures, Human BAG 1/RAP46 is generated as three isoforms by alternative translation initiation and is overexpressed in human cancer cells., American Association for Cancer Research Annual Meeting | 1998 |
National and International Invited Seminars/Lectures, Distinct patterns of HPV-16 infections in native epithelium and in metaplasia., The American Society of Virology 17th Annual Meeting | 1998 |
State/Local Invited Seminars/Lectures, Cloning of the gene encoding lymphocyte differentiation antigen CD9., New Frontiers in Cancer Research | 1998 |
State/Local Invited Seminars/Lectures, Prognostic value of BAG-1 in invasive breast cancer: a retrospective study., Second Atlantic Canada Group Winter Symposium | 1998 |
Poster Presentation, Distinct Patterns of HPV-16 Infections in VIN 1 in Native Epithelium and CIN 1 in Metaplasia, Proceedings of 16th International Papillomavirus Conference, Siena, Italy | 09/1997 |
National and International Invited Seminars/Lectures, Prognostic Value of BAG-1 in Non-Small Cell Lung Cancer, Manitoba Cancer Treatment and Research Foundation | 1997 |
National and International Invited Seminars/Lectures, Cancer Gene Therapy: Fiction or Reality, Canadian Cancer Society Annual Conference, St. John's, NF, Canada | 1997 |
National and International Invited Seminars/Lectures, BAG-1, A New Player in Apoptosis, Ontario Cancer Treatment and Research Foundation, Sudbury, ON, Canada | 1997 |
National and International Invited Seminars/Lectures, Update in Lung Cancer Chemotherapy, ASCO Review, St. Johns, NF, Canada | 1997 |
National and International Invited Seminars/Lectures, Advanced NSCLC, Role of Systemic chemotherapy, 1st Atlantic Canada Oncology Group Annual Symposium, Corner Brook, NF, Canada | 1997 |
National and International Invited Seminars/Lectures, Systemic Therapy for Advanced Non-Small Cell Lung Cancer, Ontario Cancer Treatment and Research Foundation, Sudbury, ON, Canada | 1997 |
National and International Invited Seminars/Lectures, BAG-1, The New Player in Apoptosis, British Columbia Cancer Agency, Vancouver, BC, Canada | 1997 |
National and International Invited Seminars/Lectures, Are There Any Useful Markers for the Prognosis of Lung Cancer?, Nova Scotia Cancer Treatment and Research Foundation, Halifax, NS, Canada | 1997 |
National and International Invited Seminars/Lectures, New Markers for the Prognosis of Lung Cancers, University of Manitoba, Winnipeg, Manitoba | 1997 |
National and International Invited Seminars/Lectures, Distinct patterns of HPV-16 infections in native epithelium and in metaplasia., 16th International Papillomavirus Workshop | 1997 |
National and International Invited Seminars/Lectures, Cloning and characterization of human BAG-1, a protein interacting with Bcl-2., American Association for Cancer Research Annual Meeting | 1997 |
State/Local Invited Seminars/Lectures, Prolonged, severe 5-fluorouracil-associated neurotoxicity in patient with dihydropyridine dehydrogenase deficiency., Royal College of Physicians and Surgeons of Canada Annual Meeting, Canada | 1997 |
National and International Invited Seminars/Lectures, Advanced Lung Carcinoma: Who Should we Treat?, NCTRF Annual Cancer Conference, St. John's, NF, Canada | 1996 |
National and International Invited Seminars/Lectures, Update in Lung Cancer Chemotherapy, Nova Scotia Cancer Treatment and Research Foundation, Halifax, NS, Canada | 1996 |
Poster Presentation, Objective Clinical Responses in Patients with Progressive/Recurrent Low-Grade Lymphoma Treated with Campath-1H Monoclonal Antibody, Proceedings of Annual Meeting of American Society Clinical Oncology, Baltimore, MD | 1995 |
National and International Invited Seminars/Lectures, Objective clinical responses in patients with progressive/recurrent low-grade lymphoma treated with Campath-1H monoclonal antibody., American Society of Clinical Oncology Annual Conference | 1995 |
National and International Invited Seminars/Lectures, Campath-1H monoclonal antibody can induce objective clinical response in patients with recurrent low-grade lymphoma., American Society of Hematology Annual Conference | 1994 |
State/Local Invited Seminars/Lectures, Molecular cloning of the human lymphocyte differentiation antigen CD9., Heritage Research Day | 1988 |
State/Local Invited Seminars/Lectures, Structural relationships of the membrane glycoproteins gp22 and gp24., Third Terry Fox Cancer Research Conference | 1985 |
Poster Presentation, A New Approach for Chemical-enzymatic Synthesis of IFN-Y Gene and Strategy of Site-specific Mutagenesis, International Congress for Virology, Sendai, Japan | 09/1984 |
Poster Presentation, Site-specific Mutagenesis of RNA Genome, International Congress for Virology, Sendai, Japan | 09/1984 |
National and International Invited Seminars/Lectures, Protein engineering of IFN by using novel approaches for chemical enzymatic gene synthesis and fragment replacement method for site-specific mutagenesis., Antiviral Research | 1984 |
National and International Invited Seminars/Lectures, Site-specific mutagenesis of RNA genome., Sixth International Congress of Virology | 1984 |
National and International Invited Seminars/Lectures, Gene synthesis, site-specific mutagenesis for protein and RNA engineering., Sixth International Congress of Virology | 1984 |
State/Local Invited Seminars/Lectures, Site-specific mutagenesis and protein engineering of IFN., Heritage Research Day, Canada | 1984 |
National and International Invited Seminars/Lectures, Update on chemotherapy in MBC, UCLA Santa Monica Clinic, Los Angeles, CA | |
National and International Invited Seminars/Lectures, Breast Cancer, current issues, University of Minnesota Radiation Oncology Fellows course, Minnesota | |
National and International Invited Seminars/Lectures, American Society of Clinical Oncology Annual meeting Review in Breast Cancer, Central Alabama Hematology and Oncology Forum, Birmingham, Alabama | |
State/Local Invited Seminars/Lectures, BAG-1 expression correlates with survival in patients with non-small cell lung carcinoma., The United States-Canadian Academy of Pathology | |